{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:29:27Z","timestamp":1773480567893,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.jocn.2006.03.020","type":"journal-article","created":{"date-parts":[[2007,5,30]],"date-time":"2007-05-30T11:58:18Z","timestamp":1180526298000},"page":"625-629","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacoeconomics of therapy for Guillain\u2013Barr\u00e9 syndrome: plasma exchange and intravenous immunoglobulin"],"prefix":"10.1016","volume":"14","author":[{"given":"Ching-Piao","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yung","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Chi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2006.03.020_bib1","first-page":"565","article-title":"Criteria for the diagnosis of Guillain\u2013Barr\u00e9 syndrome","volume":"3","author":"Asbury","year":"1978","journal-title":"Ann Neurol"},{"issue":"Suppl. 2","key":"10.1016\/j.jocn.2006.03.020_bib2","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiological features of Guillain\u2013Barr\u00e9 syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jocn.2006.03.020_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(84)90819-5","article-title":"Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"2","author":"Osterman","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2006.03.020_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"Appropriate number of plasma exchanges in Guillain\u2013Barr\u00e9 syndrome","volume":"41","author":"French Cooperative Group on Plasma Exchange in Guillain\u2013Barr\u00e9 Syndrome","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2006.03.020_bib5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/jnnp.54.11.957","article-title":"Treatment related fluctuations in Guillain\u2013Barr\u00e9 syndrome after high-dose immunoglobulins or plasma\u2013exchange","volume":"54","author":"Kleyweg","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2006.03.020_bib6","doi-asserted-by":"crossref","unstructured":"Van der Mech\u00e9 FGA, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain\u2013Barr\u00e9 syndrome. Dutch Guillain\u2013Barr\u00e9 Study Group. N Engl J Med 1992;326:1123\u20139.","DOI":"10.1056\/NEJM199204233261705"},{"key":"10.1016\/j.jocn.2006.03.020_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain\u2013Barr\u00e9 syndrome","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain\u2013Barr\u00e9 Syndrome Trial Group","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2006.03.020_bib8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain\u2013Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2006.03.020_bib9","first-page":"6","article-title":"Introduction to pharmacoeconomic principles and application in pharmacy practice","volume":"14","author":"Venturini","year":"2002","journal-title":"Calif J Health Syst Pharm"},{"key":"10.1016\/j.jocn.2006.03.020_bib10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1351-5101.2003.00701.x","article-title":"Cost\u2013utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"10","author":"McCrone","year":"2003","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2006.03.020_bib11","series-title":"Methods for the Economic Evaluation of Health Care Programs","author":"Drummond","year":"1997"},{"key":"10.1016\/j.jocn.2006.03.020_bib12","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain\u2013Barr\u00e9 syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"Suppl","key":"10.1016\/j.jocn.2006.03.020_bib13","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain\u2013Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2006.03.020_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2165\/00003495-200464060-00003","article-title":"Guillain\u2013Barr\u00e9 Syndrome: Epidemiology, pathophysiology and management","volume":"64","author":"Kuwabara","year":"2004","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.jocn.2006.03.020_bib15","first-page":"CD001446","article-title":"Corticosteroids for treating Guillain\u2013Barr\u00e9 syndrome","author":"Hughes","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jocn.2006.03.020_bib16","first-page":"CD002063","article-title":"Intravenous immunoglobulin for Guillain\u2013Barr\u00e9 syndrome","author":"Hughes","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.jocn.2006.03.020_bib17","first-page":"CD001798","article-title":"Plasma exchange for Guillain\u2013Barr\u00e9 syndrome","author":"Raphael","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jocn.2006.03.020_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/WNL.37.5.837","article-title":"Guillain\u2013Barr\u00e9 syndrome: quantitative measurement of plasma exchange therapy","volume":"37","author":"Farkkila","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2006.03.020_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0140-6736(84)91341-2","article-title":"Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy","volume":"1","author":"Greenwood","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2006.03.020_bib20","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.410220612","article-title":"Efficiency of plasma exchange in Guillain\u2013Barr\u00e9 syndrome: role of replacement fluids","volume":"22","author":"French Cooperative Group on Plasma Exchange in Guillain\u2013Barr\u00e9 Syndrome","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2006.03.020_bib21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High dose intravenous gammaglobulin for idiopathic thrombocytopaenic purpura","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2006.03.020_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-510X(85)90173-X","article-title":"Plasma and gammaglobulin infusion in chronic inflammatory polyneuropathy","volume":"70","author":"Vermeulin","year":"1985","journal-title":"J Neurol Sci"},{"issue":"Suppl.1","key":"10.1016\/j.jocn.2006.03.020_bib23","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00003246-200301001-00002","article-title":"Economic evaluation of new therapies in critical illness","volume":"31","author":"Coughlin","year":"2003","journal-title":"Crit Care Med"},{"issue":"Suppl.2","key":"10.1016\/j.jocn.2006.03.020_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/513785","article-title":"The economic burden of Campylobacter\u2013associated Guillain\u2013Barr\u00e9 syndrome","volume":"176","author":"Buzby","year":"1997","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.jocn.2006.03.020_bib25","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1093\/infdis\/175.Supplement_1.S151","article-title":"Assessment of Guillain\u2013Barr\u00e9 syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance","volume":"175","author":"Prevots","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jocn.2006.03.020_bib26","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s001340051323","article-title":"Cost\u2013effectiveness of plasma exchange therapy for the treatment of Guillain\u2013Barr\u00e9 syndrome","volume":"26","author":"Esp\u00e9rou","year":"2000","journal-title":"Intens Care Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586806002803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586806002803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T12:52:38Z","timestamp":1556455958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586806002803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0967586806002803"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2006.03.020","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}